These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31596566)

  • 1. Model-Driven Engineering of N-Linked Glycosylation in Chinese Hamster Ovary Cells.
    Stach CS; McCann MG; O'Brien CM; Le TS; Somia N; Chen X; Lee K; Fu HY; Daoutidis P; Zhao L; Hu WS; Smanski M
    ACS Synth Biol; 2019 Nov; 8(11):2524-2535. PubMed ID: 31596566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoengineering Chinese hamster ovary cells: a short history.
    Donini R; Haslam SM; Kontoravdi C
    Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells.
    Chung CY; Wang Q; Yang S; Ponce SA; Kirsch BJ; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2017 Dec; 114(12):2848-2856. PubMed ID: 28926673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells.
    Deng Z; Yi X; Chu J; Zhuang Y
    J Biotechnol; 2019 Dec; 306():159-168. PubMed ID: 31604106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.
    Spahn PN; Hansen AH; Hansen HG; Arnsdorf J; Kildegaard HF; Lewis NE
    Metab Eng; 2016 Jan; 33():52-66. PubMed ID: 26537759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoengineering design options for IgG1 in CHO cells using precise gene editing.
    Schulz MA; Tian W; Mao Y; Van Coillie J; Sun L; Larsen JS; Chen YH; Kristensen C; Vakhrushev SY; Clausen H; Yang Z
    Glycobiology; 2018 Jul; 28(7):542-549. PubMed ID: 29596681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese hamster ovary (CHO) cells may express six beta 4-galactosyltransferases (beta 4GalTs). Consequences of the loss of functional beta 4GalT-1, beta 4GalT-6, or both in CHO glycosylation mutants.
    Lee J; Sundaram S; Shaper NL; Raju TS; Stanley P
    J Biol Chem; 2001 Apr; 276(17):13924-34. PubMed ID: 11278604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation flux analysis reveals dynamic changes of intracellular glycosylation flux distribution in Chinese hamster ovary fed-batch cultures.
    Hutter S; Villiger TK; Brühlmann D; Stettler M; Broly H; Soos M; Gunawan R
    Metab Eng; 2017 Sep; 43(Pt A):9-20. PubMed ID: 28754360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical inhibitors of hexokinase-2 enzyme reduce lactate accumulation, alter glycosylation processing, and produce altered glycoforms in CHO cell cultures.
    Naik HM; Kumar S; Reddy JV; Gonzalez JE; McConnell BO; Dhara VG; Wang T; Yu M; Antoniewicz MR; Betenbaugh MJ
    Biotechnol Bioeng; 2023 Sep; 120(9):2559-2577. PubMed ID: 37148536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells.
    Kotidis P; Donini R; Arnsdorf J; Hansen AH; Voldborg BGR; Chiang AWT; Haslam SM; Betenbaugh M; Jimenez Del Val I; Lewis NE; Krambeck F; Kontoravdi C
    Metab Eng; 2023 Mar; 76():87-96. PubMed ID: 36610518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Multiplexed Editing of Chinese Hamster Ovary B4Gal-T1, 2, 3, and 4 Tailors N-Glycan Profiles of Therapeutics and Secreted Host Cell Proteins.
    Amann T; Hansen AH; Kol S; Lee GM; Andersen MR; Kildegaard HF
    Biotechnol J; 2018 Oct; 13(10):e1800111. PubMed ID: 29862652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles.
    Amann T; Hansen AH; Kol S; Hansen HG; Arnsdorf J; Nallapareddy S; Voldborg B; Lee GM; Andersen MR; Kildegaard HF
    Metab Eng; 2019 Mar; 52():143-152. PubMed ID: 30513349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A; Shanmugam D; Gadgil M
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.